Indication
Refractory Chronic Cough
7 clinical trials
10 products
Product
BLU-5937Clinical trial
A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic CoughStatus: Recruiting, Estimated PCD: 2025-09-01
Product
PlaceboClinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ib/II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of TCR1672 Tablets in Patients With Refractory Chronic CoughStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Product
TCR1672Clinical trial
A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Efficacy and Safety Study With Open-Label Extension of BLU-5937 in Adult Participants With Refractory Chronic Cough, Including Unexplained Chronic CoughStatus: Recruiting, Estimated PCD: 2025-09-01
Product
NalbuphineClinical trial
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Two-Period Crossover Efficacy and Safety Study of Nalbuphine ER Tablets for the Treatment of Refractory Chronic CoughStatus: Recruiting, Estimated PCD: 2024-09-01
Product
HRS-2261Clinical trial
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Study of Efficacy and Safety of HRS-2261 in Refractory Chronic CoughStatus: , Estimated PCD: 2024-03-30
Product
NOC-100Product
1 mg NOC-110Clinical trial
A Phase 1, Two Part, Placebo-controlled, Single Dose Study in Healthy Volunteers and Multiple Dose Study in Patients With Refractory Chronic Cough to Assess the Safety, Tolerability, and PK of NTX-1175 Administered Via Nebulizer (NOC-100) and Dry Powder Inhaler (NOC-110)Status: Completed, Estimated PCD: 2022-10-25
Product
NOC-110Clinical trial
A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic CoughStatus: Recruiting, Estimated PCD: 2025-12-01
Product
DuloxetineProduct
Amitriptyline